Who
Kanya Rajangam
Pres. & Chief Med. & Dev. Off.
Company insider
Files Form 4 as: Pres. & Chief Med. & Dev. Off., Senti Biosciences Holdings; Director, Turnstone Biologics; Chief Medical Officer, Nkarta.
In numbers
- Trades disclosed
- 25
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $379K
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 9 Jul 2020
- Last trade
- 9 Mar 2026
- Last filed
- 11 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Mar 2026filed 11 Mar 2026 | SNTI Senti Biosciences HoldingsBiotechnology | SEC FORM 4 Code F | —10,757 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | SNTI Senti Biosciences HoldingsBiotechnology | SEC FORM 4 Code F | —10,757 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | SNTI Senti Biosciences HoldingsBiotechnology | SEC FORM 4 Code F | —1,384 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | SNTI Senti Biosciences HoldingsBiotechnology | SEC FORM 4 Code F | —1,384 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | SNTI Senti Biosciences Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code C | $74K33 at $2,250.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | SNTI Senti Biosciences HoldingsBiotechnology | SEC FORM 4 Code C | $74K33,000 at $2.25 | filing |
| 7 Mar 2025filed 10 Mar 2025 | SNTI Senti Biosciences HoldingsBiotechnology | SEC FORM 4 Code A | —78,363 at $0.00 | filing |
| 6 Mar 2025filed 10 Mar 2025 | SNTI Senti Biosciences Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —235,088 at $0.00 | filing |
| 6 Feb 2025filed 6 Feb 2025 | SNTI Senti Biosciences HoldingsBiotechnology | SEC FORM 4 Sold | $795182 at $4.37 | filing |
| 4 Feb 2025filed 6 Feb 2025 | SNTI Senti Biosciences HoldingsBiotechnology | SEC FORM 4 Sold | $5,2791,297 at $4.07 | filing |
| 9 Dec 2024filed 10 Dec 2024 | SNTI Senti Biosciences Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | $74K33 at $2,250.00 | filing |
| 9 Dec 2024filed 10 Dec 2024 | SNTI Senti Biosciences Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —49,500 at $0.00 | filing |
| 3 Jun 2024filed 2 Jul 2024 | Turnstone Biologicsoption or derivative | SEC FORM 4 Code A | —12,770 at $0.00 | filing |
| 1 Feb 2024filed 2 Feb 2024 | SNTI Senti Biosciences Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —152,000 at $0.00 | filing |
| 1 Feb 2024filed 2 Feb 2024 | SNTI Senti Biosciences HoldingsBiotechnology | SEC FORM 4 Code A | —101,000 at $0.00 | filing |
| 16 Oct 2023filed 17 Oct 2023 | Turnstone Biologicsoption or derivative | SEC FORM 4 Code A | —8,012 at $0.00 | filing |
| 1 Feb 2023filed 2 Feb 2023 | SNTI Senti Biosciences Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 18 Jul 2022filed 20 Jul 2022 | SNTI Senti Biosciences Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —327,750 at $0.00 | filing |
| 14 Jan 2022filed 19 Jan 2022 | NKTX Nkartaoption or derivative · Biotechnology | SEC FORM 4 Code A | —76,800 at $0.00 | filing |
| 14 Jan 2022filed 19 Jan 2022 | NKTX NkartaBiotechnology | SEC FORM 4 Code A | —12,800 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.